MedTrace Logo

Adherence to Aromatase Inhibitors: The Role of Partners

NCT02753985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2019-07-23

No results posted yet for this study

Summary

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

Conditions

  • Breast Cancer Survivors

Interventions

OTHER

Survey

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Jun Mao, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-04-22
Completion
2016-04-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02753985 on ClinicalTrials.gov